STAT on Mythryl: “A targeted drug from Incyte, when used in combination with…”

A targeted drug from Incyte, when used in combination with chemotherapy, induced lasting tumor responses in certain patients with pancreatic cancer. https://www.statnews.com/2026/10/26/incyte-esmo-pancreatic-cancer-incb161734-results/

26/10/26, 3:59 pm6 reposts14 likes

Post